Herceptin isn’t the only treatment for breast cancer that works on HER2. If your HER2-positive breast cancer grows while you’re taking Herceptin, there may be other targeted treatments you ...

Treatment with Herceptin may cause serious side effects. In studies, serious side effects weren’t as common in people using Herceptin to treat breast cancer as they were in people with stomach ...

Breast Cancer Drug Herceptin May Work Just As Well With Much Briefer Treatment : Shots - Health News An aggressive type of breast cancer — a HER2-positive tumor — often shrinks with Herceptin ...

Herceptin Treatment Lowers Recurrence Rate In Early Breast Cancer. ScienceDaily . Retrieved June 4, 2025 from www.sciencedaily.com / releases / 2005 / 10 / 051022234245.htm ...

New Approach in Breast Cancer Treatment. The first international clinical trial of Herceptin involved more than 5,000 women with HER2-positive breast cancer who had already undergone standard ...

In 1998, the FDA approved Herceptin for the treatment of metastatic breast cancer (cancer that has spread to other places in the body).

An aggressive type of breast cancer — a HER2-positive tumor — often shrinks with Herceptin treatment, but side effects can be tough. Researchers say a shorter course of the drug may be a good ...

Herceptin has relatively few side effects, but certainly the one that has troubled us the most is that there is a small, but real, chance of developing heart damage as a consequence of Herceptin, ...

This means that Roche’s one-year Herceptin treatment will remain the standard therapy for patients suffering from early-stage HER2-positive breast cancer. The study did not have any new safety ...

An aggressive type of breast cancer — a HER2-positive tumor — often shrinks with Herceptin treatment, but side effects can be tough. Researchers say a shorter course of the drug may be a good ...